All News about Takeda Pharmaceutical Ord Shs![]() ![]() ![]() ![]() ![]()
Takeda To Add Mid-Stage Autoimmune Disease Candidate For $4B
December 13, 2022
Via Benzinga
![]()
Takeda's Dengue Vaccine Candidate Under FDA Priority Review
November 23, 2022
Via Benzinga
![]()
Takeda Posts Lower 1H Profit, Lifts FY22 Outlook
October 27, 2022
Via Benzinga
![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |